- Home
- ANGO vs MIY Comparison
ANGO vs MIY Comparison
Compare ANGO & MIY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGO
- MIY
- Stock Information
- Founded
- ANGO 1988
- MIY 1992
- Country
- ANGO United States
- MIY United States
- Employees
- ANGO N/A
- MIY N/A
- Industry
- ANGO Medical/Dental Instruments
- MIY Investment Bankers/Brokers/Service
- Sector
- ANGO Health Care
- MIY Finance
- Exchange
- ANGO Nasdaq
- MIY Nasdaq
- Market Cap
- ANGO 400.8M
- MIY 326.1M
- IPO Year
- ANGO 2004
- MIY N/A
- Fundamental
- Price
- ANGO $12.45
- MIY $11.70
- Analyst Decision
- ANGO Strong Buy
- MIY
- Analyst Count
- ANGO 3
- MIY 0
- Target Price
- ANGO $19.33
- MIY N/A
- AVG Volume (30 Days)
- ANGO 466.5K
- MIY 56.8K
- Earning Date
- ANGO 01-07-2026
- MIY 01-01-0001
- Dividend Yield
- ANGO N/A
- MIY 3.98%
- EPS Growth
- ANGO N/A
- MIY N/A
- EPS
- ANGO N/A
- MIY N/A
- Revenue
- ANGO $300,718,000.00
- MIY N/A
- Revenue This Year
- ANGO $8.18
- MIY N/A
- Revenue Next Year
- ANGO $5.15
- MIY N/A
- P/E Ratio
- ANGO N/A
- MIY N/A
- Revenue Growth
- ANGO 2.73
- MIY N/A
- 52 Week Low
- ANGO $6.91
- MIY $9.45
- 52 Week High
- ANGO $13.50
- MIY $11.70
- Technical
- Relative Strength Index (RSI)
- ANGO 58.66
- MIY 63.02
- Support Level
- ANGO $11.35
- MIY $11.42
- Resistance Level
- ANGO $12.50
- MIY $11.67
- Average True Range (ATR)
- ANGO 0.44
- MIY 0.10
- MACD
- ANGO 0.00
- MIY 0.01
- Stochastic Oscillator
- ANGO 74.52
- MIY 100.00
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
About MIY Blackrock MuniYield Michigan Quality Fund Inc.
Blackrock Muniyield Michigan Quality Fund Inc is a closed end fund. Its investment objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes and New York State and New York City personal income taxes as is consistent with its investment policies and prudent investment management.